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Summary
Mo¨bius syndrome (MIM 157900) consists of a congen-
ital paresis or paralysis of the VIIth (facial) cranial nerve,
frequently accompanied by dysfunction of other cranial
nerves. The abducens nerve is typically affected, and
often, also, the hypoglossal nerve. In addition, orofacial
and limb malformations, defects of the musculoskeletal
system, and mental retardation are seen in patients with
Mo¨bius syndrome. Most cases are sporadic, but familial
recurrence can occur. Different modes of inheritance are
suggested by different pedigrees. Genetic heterogeneity
of Mo¨bius syndrome has been suggested by cytogenetic
studies and linkage analysis. Previously, we identified a
locus on chromosome 3q21-22, in a large Dutch family
with Mo¨bius syndrome consisting essentially of auto-
somal dominant asymmetric bilateral facial paresis. Here
we report linkage analysis in a second large Dutch family
with autosomal dominant inherited facial paresis. After
exclusion of 190% of the genome, we identified the locus
on the long arm of chromosome 10 in this family, dem-
onstrating genetic heterogeneity of this condition. The
reduced penetrance suggests that at least some of the
sporadic cases might be familial.
Introduction
Mo¨bius syndrome (MBS; MIM 157900) is a rare con-
genital disorder involving complete or partial facial
nerve palsy, either unilateral or bilateral, with or without
paralysis of other cranial nerves. In particular, the ab-
ducens nerve is typically affected and often, also, the
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hypoglossal nerve. Malformations of the limbs occur
frequently and include syndactyly, ectrodactyly, brachy-
dactyly, and talipes equinovarus. Facial dysmorphisms,
such as micrognathia, prominent epicanthic folds, and
a broad flat nose, may also occur. Furthermore, struc-
tural abnormalities of the ear, defective branchial mus-
culature (especially absence of the pectoral muscle), and
mild mental retardation can accompany the cranial
nerve palsy (Sudarshan and Goldie 1985; Kumar 1990).
Only a minority of cases of congenital facial paralysis
are uncomplicated by other cranial nerve palsies; in this
group, deformities of the limbs are rare (Henderson
1939).
The etiology and the pathogenesis of the syndrome
are uncertain. It is probable that the site, nature, and
extent of the lesion are somewhat different in various
cases (Hicks 1943; Towfighi et al. 1979). The two major
explanations suggested for this type of cranial nerve dys-
function are (1) a primary metameric defect in the brain
stem nuclei in the region of the tegmentum and (2) an
ischemic process resulting from an interruption of the
vascular supply of the brain stem during early fetal de-
velopment. These rather divergent proposed mechanisms
are based on limited pathological observations in pa-
tients with MBS. Agenesis or hypoplasia of the central
brain stem nuclei and brain stem atrophy as a cause of
peripheral nerve involvement or myopathy are observed.
Hypoplasia of cranial nerve nuclei with active neuronal
degeneration or with focal necrosis, gliosis, and calci-
fication has been described as well (Kumar 1990).
The majority of the published reports on MBS refer
to sporadic cases without any evidence of a known en-
vironmental causative factor, but familial occurrence has
been described as well. The patterns of inheritance in
families with the syndrome suggest different modes of
inheritance: autosomal dominant, autosomal recessive,
and X-linked recessive. Variable expression and de-
creased penetrance could explain the lack of clear Men-
delian inheritance patterns in individuals in these fam-
ilies (Legum et al. 1981; Wishnick et al. 1981). Several
genetic loci have been implicated in MBS. On the basis
of the 46,XX,del(13)(q12.2) karyotype in a sporadic pa-
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Table 1
Two-Point LOD Scores between the Polymorphic Markers Derived
from Chromosome 10 and MBS in the Present Family
LOCUS
LOD SCORE AT v =
vmax LODmax.00 .05 .10 .20 .30 .40
D10S196  1.01 .01 .68 .70 .41 .25 .74
D10S539  .48 1.28 1.68 1.42 .78 .20 1.68
D10S589 4.65 1.74 2.14 2.08 1.54 .78 .14 2.20
D10S581 .51 4.47 4.33 3.52 2.36 1.04 .05 4.47
D10S557 2.38 2.26 2.09 1.64 1.10 .53 .00 2.38
D10S1241 2.86 2.77 2.60 2.02 1.23 .40 .00 2.86
D10S599 1.76 1.61 1.45 1.10 .74 .37 .00 1.76
D10S502 5.42 .71 1.19 1.32 .98 .44 .17 1.35
D10S1670 .21 2.74 2.87 2.59 1.92 1.01 .10 2.87
D10S522 1.72 1.37 1.50 1.36 .98 .48 .11 1.51
D10S1646 8.57 1.50 .79 .11 .18 .21 .36 .22
D10S210 .21 2.59 2.61 2.19 1.52 .76 .08 2.63
D10S1647 1.08 1.62 1.81 1.67 1.23 .65 .12 1.82
D10S1678 3.42 .76 .49 .19 .00 .08 .40 .08
D10S1672 .34 2.62 2.79 2.54 1.90 1.01 .11 2.79
tient (Slee et al. 1991) and of the cosegregation of the
translocation t(1;13)(p34;q13) with the syndrome in a
three-generation family (Ziter et al. 1977), 13q12.2-q13
is thought to harbor a locus for MBS. In two sporadic
patients, the karyotypes 46,XY,t(1;11)(p22;p13) (Don-
ahue et al. 1993) and 46,XY,t(1;2)(p22;q21.1) (Nishi-
kawa et al. 1997) raise the possibility that another gene
for MBS is located in or near band p22 on chromosome
1. Previously, we localized a gene for autosomal domi-
nant congenital facial paralysis in a Dutch family to
chromosome 3q21-22 (Kremer et al. 1996).
In the present study, we performed linkage analysis in
a second Dutch family partly described elsewhere (For-
tanier and Speijer 1935; Nicolai et al. 1986). The phe-
notype in this family is characterized by unilateral or
asymmetric bilateral congenital facial paralysis; in some
cases, deafness occurs. After exclusion of 190% of the
genome, including the candidate regions, we localized
the gene involved in MBS in this family to the long arm
of chromosome 10.
Patients and Methods
Patients
We examined MBS patients in the family, one branch
of which was described by Fortanier and Speijer (For-
tanier and Speijer 1935) and two members of which were
described by Nicolai et al. (1986). Affected members of
this family have unilateral or bilateral facial weakness.
Weakness of the muscles of the three branches of the
facial nerve varies among individuals. Besides facial
weakness, hearing loss is present in a number of patients,
ranging from congenital deafness to progressive hearing
loss with age. In one patient with hearing loss, there is
a deformity of the os petrosum. Unaffected members of
this family lack congenital hearing loss as well as facial
paralysis, examined with specific functional facial tests
on neurologic examination.
Typing of DNA Markers
Genomic DNA used for the typing of the DNA poly-
morphisms was isolated as described by Miller et al.
(1988). Amplification of the polymorphic regions and
analysis of the amplified fragments were performed ac-
cording to Kremer et al. (1994).
Statistical Evaluation
We calculated two-point LOD scores, using the sub-
routine MLINK of the LINKAGE program (version 5.1)
(Lathrop and Lalouel 1984; Lathrop et al. 1984, 1986).
Multipoint analysis was performed by means of five-
point linkage analysis (FASTLINK version 2.30) (Cot-
tingham et al. 1993; Schaffer et al. 1994) combined with
the sliding window technique. A mutated MBS allele
frequency of .00001 and a penetrance of 80% were as-
sumed. The penetrance was deduced from the number
of clinically affected persons (21) and the number of
obligate gene carriers (6). The order of the markers is
according to the Ge´ne´thon map and the chromosome
10 contig by Genome Therapeutics Corpora-
tion.
Results
Linkage to Chromosome 10q21.3-22.1
We performed linkage analysis in this second Dutch
family with autosomal dominant MBS (Fortanier and
Speijer 1935; Nicolai et al. 1986). Fifty-six persons were
included in the DNA analysis, 19 of whom were affected
and 5 of whom were obligate carriers.
We excluded the MBS locus on 3q and the regions
involved in chromosomal abnormalities of MBS patients
on chromosome 1, 2, 11, and 13. Subsequently, a ran-
dom genome scan was initiated with polymorphic mark-
ers spaced 10–15 cM apart. After exclusion of 190% of
the genome, an indication for linkage was obtained with
marker D10S606 on the long arm of chromosome 10.
The maximum LOD score was 2.02 at recombination
fraction (v) 0.06. Exclusion of the region distal to
D10S606 pointed to a more proximal location of the
disease gene.
Fine Mapping
For fine mapping of the gene, 15 polymorphic markers
derived from the region proximal to D10S606 were
tested (Genome Database, Ge´ne´thon, Genome Thera-
peutics Corporation, GeneMap’99). Two-point LOD
scores between the relevant markers and the disease lo-
Figure 1 Pedigree of the family and haplotypes of individuals available for this study. The ancestral mutation-bearing chromosome is boxed. Lines beside the haplotypes mark the part of the
ancestral chromosome present in the patients. Deduced haplotypes are given between brackets.
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Figure 2 Five-point linkage analysis combined with the sliding
window technique, resulting in a maximum LOD score of 6.2 in the
interval between D10S581 and D10S557.
cus are given in table 1. A maximum LOD score of 4.47
at was obtained with the marker D10S581.v = 0.05
Haplotypes were constructed to define the borders of
the cosegregating region (fig. 1). The proximal border
of the critical region is determined by a recombination,
present in individuals V:13 and V:20, between the mark-
ers D10S581 and D10S557. The distal border of the
region is determined by a recombination, present in in-
dividual V:7, between the markers D10S599 and
D10S502. Besides the five obligate carriers, nine clini-
cally unaffected individuals (IV:15, V:8, V:11, V:15, V:
16, V:21, V:24, VI:13, and VI:17) underline the incom-
plete penetrance in this family because, for the relevant
interval, they carry the chromosomal fragment that co-
segregates with the syndrome. Therefore, after linkage
had been established in this family, the penetrance was
recalculated, leading to a value of 60%.
Five-point linkage analysis was performed to deter-
mine the location of the gene involved with the highest
likelihood (fig. 2). The analysis resulted in the maximum
LOD score of 6.2 in the interval flanked by the markers
D10S581 and D10S557.
Discussion
In the present study, linkage analysis enabled us to
localize a gene responsible for autosomal dominant in-
herited MBS to the long arm of chromosome 10. Here-
with, we have demonstrated genetic heterogeneity for
autosomal dominant MBS, since we previously described
a locus for MBS on chromosome 3q21-22 (Kremer et
al. 1996). The critical region that is delimited by the
markers D10S581 and D10S502 spans ∼3.7 cM at
10q21.3-22.1 (Ge´ne´thon). The early growth response 2
gene (EGR2) maps to this interval (GeneMap’99) and
is an interesting candidate gene, since disruption of the
mouse orthologue, also known as Krox-20, results in
elimination of rhombomeres 3 and 5 and thus affects
the motor nuclei of cranial nerves V, VI, VII, and IX
(Schneider-Mannoury et al. 1993).
The penetrance in the present family is 60%, given
the five obligate carriers and nine clinically unaffected
individuals in which haplotypes of the critical region
show the “affected” genotype. In contrast, the pene-
trance in the first Dutch family with autosomal domi-
nantly segregating MBS is 95% (Kremer et al. 1996).
The reduced penetrance seen in the present family sug-
gests that at least some of the seemingly sporadic cases
might be members of a (small) family with a low pen-
etrance of MBS. Furthermore, the reduced penetrance
for MBS indicates that other factors, genetic or nonge-
netic, influence the development of the condition.
Pathogenetically, we assume that there are at least two
different groups of patients with MBS. One group con-
sists of patients with autosomal dominant congenital
facial palsy, in which agenesis or hypoplasia of the cra-
nial nerve nuclei is pathologically present. The palsy in
this group is caused by genetic factors, and any occurring
nonpenetrance might be explained by genetic as well as
nongenetic factors. A second group of patients with con-
genital facial palsy is characterized by hypoplasia of cra-
nial nerve nuclei, accompanied by necrosis, gliosis, and
calcifications secondary to ischemia. The postulated is-
chemia of the brainstem in these cases might be ex-
plained as a primary (genetic) or a secondary (environ-
mental) mechanism (Pastuszak et al. 1998). At present,
it is unclear which part of MBS is caused by genetic and
which part by nongenetic factors. Identification of the
gene involved in the present family and subsequent mu-
tation analysis in sporadic patients might shed some light
on this question and on cranial nerve and brainstem
development.
Acknowledgments
We are grateful to the family members who participated in
this study. We would like to thank M. R. Nelen, Ing., and Dr.
756 Am. J. Hum. Genet. 65:752–756, 1999
M. M. M. van Reen for their support and helpful discussions,
and Ir. K. Cuelenaere (CAOS/CAMM Center) for technical
assistance. B.v.d.H. was supported by a grant from the Prinses
Beatrix Fonds.
Electronic-Database Information
Accession numbers and URLs for data in this article are as
follows:
GeneMap’99, http://www.ncbi.nlm.nih.gov/genemap99/
Ge´ne´thon, http://ftp.genethon.fr/genethon_en.html
Genome Database, http://www.gdb.org/
Genome Therapeutics Corporation, http://web.genomecorp
.com/genesequences/
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim (for MBS, MIM 157900)
References
Cottingham R Jr, Idury R, Schaffer A (1993) Faster sequential
genetic linkage computations. Am J Hum Genet 53:252–263
Donahue S, Wenger S, Steele M, Gorin M (1993) Broad-spec-
trum Mo¨bius syndrome associated with a 1;11 chromosome
translocation. Ophthalmic Paediatr Genet 14:17–21
Fortanier A, Speijer N (1935) Eine Erblichkeitsforschung bei
einer Familie mit angeborenen Bewechlichkeitsstorung der
Hinnerven (Infantiler Kernschwund von Moebius). Genetica
17:471–486
Henderson J (1939) The congenital facial diplegia syndrome:
clinical features, pathology and aetiology. Brain 62:381–403
Hicks A (1943) Congenital paralysis of lateral rotators of eyes
with paralysis of muscles of face. Arch Ophthalmol 30:
38–42
Kremer H, Kuyt LP, van den Helm B, van Reen M, Leunissen
JAM, Hamel BC, Jansen C, et al (1996) Localization of a
gene for Mo¨bius syndrome to chromosome 3q by linkage
analysis in a Dutch family. Hum Mol Genet 5:1367–1371
Kremer H, Pinckers A, van den Helm B, Deutman A, Ropers
H, Mariman E (1994) Localization of the gene for dominant
cystoid macular dystrophy on chromosome 7p. Hum Mol
Genet 3:299–302
Kumar D (1990) Moebius syndrome. J Med Genet 27:122–126
Lathrop G, Lalouel J (1984) Easy calculations of lod scores
and genetic risks on small computers. Am J Hum Genet 36:
460–465
Lathrop G, Lalouel J, Julier C, Ott J (1984) Strategies for
multilocus linkage analysis in humans. Proc Natl Acad Sci
USA 81:3443–3446
Lathrop G, Lalouel J, White R (1986) Construction of human
linkage maps: likelihood calculations for multilocus linkage
analysis. Genet Epidemiol 3:39–52
Legum C, Godel V, Nemet P (1981) Heterogeneity and plei-
otropism in the Moebius syndrome. Clin Genet 20:254–259
Miller S, Dykes D, Polesky H (1988) A simple salting out
procedure for extracting DNA from human nucleated cells.
Nucleic Acids Res 16:1215
Nicolai J, Bos M, ter Haar B (1986) Hereditary congenital
facial paralysis. Scand J Plast Reconstr Surg 20:37–39
Nishikawa M, Ichiyama T, Hayashi T, Furukawa S (1997)
Mobius-like syndrome associated with a 1;2 chromosome
translocation. Clin Genet 51:122–123
Pastuszak A, Schu¨ler L, Speck-Martins C, Coelho K, Cordello
S, Vargas F, Brunoni D, et al (1998) Use of Misoprostol
during pregnancy and Mo¨bius syndrome in infants. N Engl
J Med 338:1881–1885
Schaffer A, Gupta S, Shriram K, Cottingham R Jr (1994)
Avoiding recomputation in linkage analysis. Hum Hered 44:
225–237
Schneider-Manoury S, Topilko P, Seitanidou T, Levi G, Cohen-
Tannoudji M, Pournin S, Babinet C, et al. (1993) Disruption
of Krox-20 results in alteration of rhombomeres 3 and 5 in
the developing hindbrain. Cell 75:1199–1214
Slee J, Smart R, Viljoen D (1991) Deletion of chromosome 13
in Moebius syndrome. J Med Genet 28:413–414
Sudarshan A, Goldie W (1985) The spectrum of congenital
facial diplegia (Moebius syndrome). Pediatr Neurol 1:180–
184
Towfighi J, Marks K, Palmer E, Vannucci R (1979) Mobius
syndrome: neuropathologic observations. Acta Neuropathol
Berl 48:11–17
Wishnick M, Nelson L, Reich E, Hubbard L (1981) Moebius
syndrome with dominant inheritance. Am J Hum Genet 33:
96A
Ziter F, Wiser W, Robinson A (1977) Three-generation pedi-
gree of a Mobius syndrome variant with chromosome trans-
location. Arch Neurol 34:437–442
